The National Primary Health Care Agency (NPHCDA) stated 513,626 individuals have acquired the primary dose of the Oxford-AstraZeneca COVID-19 vaccine throughout the country.
The NPHCDA disclosed this in its legitimate Twitter take care of on Sunday.
The News Agency of Nigeria (NAN) reviews that Nigeria started vaccination on the grounds that March 5, first with healthcare employees who’re ordinarily liable to infections being the primary responders.
NPHCDA stated that the vaccine roll-out might be in 4 levels, beginning with fitness employees, frontline employees, COVID-19 speedy reaction team, laboratory network, policemen, petrol station employees and strategic leaders.
“Phase 2 – Older adults elderly 50 years and above, people with co-morbidities, elderly among 18 years and forty nine years.
“Phase 3 – Those in states/LGAs with excessive ailment burden and who neglected stages 1 and 2.
“Phase 4 – Other eligible populace as vaccines come to be available,’ it stated.
According to the company, as at March 28, over 513,626 eligible human beings were vaccinated in 35 states and the Federal Capital Territory (FCT).
The company stated that Kogi country is but to begin vaccination as at March 28, due to the fact the kingdom had now no longer been provided with the vaccines.
“Kogi State became now no longer provided with the vaccines due to the fact their bloodless save remains below upkeep following vandalisation at some point of the EndSARS protest,” it said.
The NPHCDA said Lagos country had vaccinated 110,042 humans, making it the best withinside the country.
It stated Ogun observed with 47,507, Kaduna-38,063, Bauchi-32,482, Katsina-28,918 and Kwara-26,473.
NPHCDA additionally stated that the states with the bottom wide variety of these vaccinated are Abia-22, Taraba-111 and Kebbi-532,
Recall that Nigeria first obtained 3.ninety four million doses of the Oxford-AstraZeneca COVID-19 vaccines and some other 300,000 doses from telecom giant, MTN, as a part of the latter’s contribution to Africa.
The Nigerian authorities hopes to vaccinate 109 million humans towards the COVID-19 virus over a duration of years.